Lv1
10 积分 2022-05-15 加入
[Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma ( version 2024)]
11小时前
已完结
[Management standards and quality control index for the clinical application of transarterial chemoembolization in the treatment of liver cancer (2024 edition)]
11小时前
已完结
[Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma ( version 2024)]
11小时前
已关闭
Hepatocellular Carcinoma: Pick the Winner—Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent–Based Combinations
2年前
已完结
90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial
2年前
已完结
皖公网安备34019202002308
